Literature DB >> 9618176

NB4S, a member of the TBC1 domain family of genes, is truncated as a result of a constitutional t(1;10)(p22;q21) chromosome translocation in a patient with stage 4S neuroblastoma.

T Roberts1, O Chernova, J K Cowell.   

Abstract

Molecular cloning of the breakpoints of a t(1;10)(p22q21) constitutional translocation breakpoint in a patient with stage 4S neuroblastoma has identified two genes which are fused in-frame to generate a novel gene. The 1p22 gene, which we have called NB4S , encodes a 7.5 kb transcript with an 810 amino acid open reading frame and is expressed in a wide variety of tissues. NB4S has >88% homology with the mouse EVI -5 gene within the coding region and shows strong homology over a 200 amino acid region with TBC1 box motif genes involved in cell growth and differentiation. The C-teminal end of the protein contains a number of coiled coil domains, indicating a possible protein-protein binding function. The chromosome 10 breakpoint interrupts a novel transcript (TRNG10) which could only be detected in tumor cells. This transcript has no exon/intron structure or significant open reading frame, suggesting that it is a structural RNA which is transcribed but not translated. The chromosome rearrangement creates a fusion gene product which combines the TBC1 motif of NB4S with a polyadenylation signal from TRNG10 , potentially generating a truncated protein with oncogenic properties.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9618176     DOI: 10.1093/hmg/7.7.1169

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  9 in total

1.  Unique ability of pandemic influenza to downregulate the genes involved in neuronal disorders.

Authors:  Esmaeil Ebrahimie; Zahra Nurollah; Mansour Ebrahimi; Farhid Hemmatzadeh; Jagoda Ignjatovic
Journal:  Mol Biol Rep       Date:  2015-08-06       Impact factor: 2.316

2.  Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma.

Authors:  Annalisa Pezzolo; Angela Rita Sementa; Margherita Lerone; Martina Morini; Marzia Ognibene; Raffaella Defferrari; Katia Mazzocco; Massimo Conte; Anna Rita Gigliotti; Alberto Garaventa; Vito Pistoia; Luigi Varesio
Journal:  Cancer Biol Ther       Date:  2017-04-12       Impact factor: 4.742

3.  Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma.

Authors:  Gunhild Trøen; Vigdis Nygaard; Tor-Kristian Jenssen; Ida Münster Ikonomou; Anne Tierens; Estella Matutes; Alicja Gruszka-Westwood; Daniel Catovsky; Ola Myklebost; Grete Lauritzsen; Eivind Hovig; Jan Delabie
Journal:  J Mol Diagn       Date:  2004-11       Impact factor: 5.568

4.  Evi9 encodes a novel zinc finger protein that physically interacts with BCL6, a known human B-cell proto-oncogene product.

Authors:  T Nakamura; Y Yamazaki; Y Saiki; M Moriyama; D A Largaespada; N A Jenkins; N G Copeland
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

5.  Common sites of retroviral integration in mouse hematopoietic tumors identified by high-throughput, single nucleotide polymorphism-based mapping and bacterial artificial chromosome hybridization.

Authors:  Haifa Shen; Takeshi Suzuki; David J Munroe; Claudia Stewart; Lynn Rasmussen; Debra J Gilbert; Nancy A Jenkins; Neal G Copeland
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  A constitutional translocation t(1;17)(p36.2;q11.2) in a neuroblastoma patient disrupts the human NBPF1 and ACCN1 genes.

Authors:  Karl Vandepoele; Vanessa Andries; Nadine Van Roy; Katrien Staes; Jo Vandesompele; Geneviève Laureys; Els De Smet; Geert Berx; Frank Speleman; Frans van Roy
Journal:  PLoS One       Date:  2008-05-21       Impact factor: 3.240

Review 7.  Non-protein coding RNA biomarkers and differential expression in cancers: a review.

Authors:  Massimo Mallardo; Palmiro Poltronieri; Oscar Fernando D'Urso
Journal:  J Exp Clin Cancer Res       Date:  2008-07-16

8.  MicroRNA-135b, a HSF1 target, promotes tumor invasion and metastasis by regulating RECK and EVI5 in hepatocellular carcinoma.

Authors:  Yan Li; Dan Xu; Chunyang Bao; Yuannv Zhang; Di Chen; Fangyu Zhao; Jie Ding; Linhui Liang; Qifeng Wang; Li Liu; Jinjun Li; Ming Yao; Shenglin Huang; Xianghuo He
Journal:  Oncotarget       Date:  2015-02-10

9.  The Evi5 oncogene promotes laryngeal cancer cells proliferation by stabilizing c-Myc protein.

Authors:  Cheng-Gang Mao; Xiao-Chun Zhou; Yi-Dao Jiang; Li-Jia Wan; Ze-Zhang Tao; Jun Guo
Journal:  Cancer Cell Int       Date:  2020-02-07       Impact factor: 5.722

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.